Visits: 1492, Avg visit time (secs): 231,01 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 779 | 52,21% | |
| /programmes.html | 118 | 7,91% |
| /lilly/programme/efsd-lilly-cds-fellowship08.html | 60 | 4,02% |
| /efsd-grant/efsd-clinresgrant-rfa08.html | 56 | 3,75% |
| /lilly/programme/efsd-lilly-cds-fellowship08.htm | 52 | 3,49% |
| /msd/albert-renold/efsd-msd-arenold.html | 45 | 3,02% |
| /lilly/programme/efsd-cds-lilly-rfa08.html | 43 | 2,88% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 31 | 2,08% |
| /new_horizons/new-horizons09.html | 31 | 2,08% |
| /dcure/efsd-dcure-rfa08.html | 26 | 1,74% |
| /gsk/efsd-gsk-rfa08.html | 24 | 1,61% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 765 | 51,27% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 97 | 6,50% |
| /efsd-grant/efsd-clinresgrant-rfa09.html | 72 | 4,83% |
| /new_horizons/new-horizons09.html | 56 | 3,75% |
| /efsd-grant/efsd-clinresgrant-rfa08.html | 56 | 3,75% |
| /msd/albert-renold/efsd-msd-arenold.html | 54 | 3,62% |
| /novartis/efsd-novartis-rfa09.html | 38 | 2,55% |
| /home.html | 34 | 2,28% |
| /lilly/programme/efsd-cds-lilly-rfa08.html | 33 | 2,21% |
| /msd/basic/efsd-msd-basic-rfa09.html | 32 | 2,14% |
| /programmes.html | 29 | 1,94% |